94 Followers on Owler

VIVUS

develops and commercializes drug therapies to treat patients with serious medical conditions... Read more
OverviewCompetitorsFundingNews & Insights

VIVUS

develops and commercializes drug therapies to treat patients with serious medical conditions... Read more
VIVUS CEO: John Amos

CEO

John Amos

CEO Approval Rating

88/100

1991

PrivateSubsidiary of Icahn Enterprises L.P.

Pharmaceuticals & Biotechnology
Pharmaceuticals
2836 NAICS listing

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
100-250
Agree?
Funding
$84.6M

News

ESG
Mar 04, 2025
Benzinga
VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management
Product Launch
Oct 30, 2024
Benzinga
VIVUS and UpScriptHealth Announce Launch of ChooseQ.online for Access to Advanced Weight Management Solutions

VIVUS Competitors

1Arena
2Orexigen Therapeutics, Inc.
3Array BioPharma
4Regeneron
5Gilead
6Bristol-Myers Squibb
7Agios
8TESARO
9Diffusion Pharmaceuticals
10Athersys
Unlock 13 + competitors

Trending Companies